Compound Detail
CHEMBL502
DONEPEZIL 💊 Approved Drug
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
💊 Approved Drug
Basic Information
| ChEMBL ID | CHEMBL502 |
| Name | DONEPEZIL |
| Phase | Approved |
| Structure Type | MOL |
| InChI Key | ADEBPBSSDYVVLD-UHFFFAOYSA-N |
| Therapeutic | ✓ Yes |
37
Targets
718
Activities
4
Assay Types
29
PK Parameters
20
Publications
4
Known Names
20
Indications
Molecular Properties
379.5
MW (Da)
4.36
ALogP
4
HBA
0
HBD
38.8
PSA (Ų)
0.75
QED
0
Ro5 Violations
6
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| First Approval | 1996 |
| Availability | Prescription |
| Chirality | Racemic |
Indications
Dementia Alzheimer Disease Anxiety Aphasia Cognitive Dysfunction Dementia, Vascular Depressive Disorder Ischemic Stroke Multiple Sclerosis Neoplasms Parkinson Disease Schizophrenia Stroke Child Development Disorders, Pervasive Cocaine-Related Disorders Delirium Diabetes Mellitus, Type 2 Fragile X Syndrome Neuralgia Supranuclear Palsy, Progressive
ATC Classification
N06DA02
donepezil
Level 1: NERVOUS SYSTEM
Level 2: PSYCHOANALEPTICS
Activity Summary
IC50 694 meas. best 8.77
Ki 21 meas. best 8.54
Kd 2 meas. best 8.1
EC50 1 meas. best 7.37
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Acetylcholinesterase CHEMBL3199 | IC50 | 8.77 | 7.8076 | 1.7 | 34 |
| Acetylcholinesterase CHEMBL220 | IC50 | 8.7 | 7.6697 | 2.0 | 155 |
| Acetylcholinesterase CHEMBL4768 | Ki | 8.54 | 8.54 | 2.9 | 2 |
| Acetylcholinesterase CHEMBL4768 | IC50 | 8.38 | 8.105 | 4.2 | 4 |
| Acetylcholinesterase CHEMBL4078 | Ki | 8.37 | 7.7075 | 4.2 | 4 |
| Cholinesterase CHEMBL5763 | IC50 | 8.34 | 5.5153 | 4.6 | 131 |
| Choline O-acetyltransferase CHEMBL3945 | IC50 | 8.28 | 8.28 | 5.3 | 1 |
| Acetylcholinesterase CHEMBL3198 | IC50 | 8.27 | 6.9489 | 5.4 | 9 |
| Acetylcholinesterase CHEMBL4078 | IC50 | 8.17 | 7.485 | 6.7 | 165 |
| Acetylcholinesterase CHEMBL220 | Ki | 8.14 | 7.79 | 7.2 | 7 |
| Acetylcholinesterase CHEMBL220 | Kd | 8.1 | 8.1 | 8.0 | 1 |
| cGMP-specific 3',5'-cyclic phosphodiesterase CHEMBL1827 | IC50 | 7.96 | 7.96 | 11.0 | 1 |
| Acetylcholinesterase CHEMBL4780 | IC50 | 7.92 | 7.63 | 12.0 | 4 |
| Cholinesterase CHEMBL1914 | IC50 | 7.85 | 5.3895 | 14.0 | 91 |
| Sigma non-opioid intracellular receptor 1 CHEMBL287 | Ki | 7.84 | 7.84 | 14.6 | 2 |
| Sigma non-opioid intracellular receptor 1 CHEMBL4153 | Ki | 7.84 | 7.84 | 14.6 | 2 |
| Beta-secretase 1 CHEMBL4822 | IC50 | 7.75 | 6.5075 | 18.0 | 8 |
| Acetylcholine receptor subunit epsilon CHEMBL2484 | IC50 | 7.49 | 7.49 | 32.4 | 1 |
| Acetylcholinesterase CHEMBL220 | EC50 | 7.37 | 7.37 | 43.0 | 1 |
| MCF7 CHEMBL387 | IC50 | 7.22 | 7.22 | 60.0 | 1 |
| HFF CHEMBL614071 | IC50 | 7.04 | 7.04 | 91.0 | 1 |
| SH-SY5Y CHEMBL614910 | IC50 | 6.52 | 4.778 | 300.0 | 5 |
| Histamine H3 receptor CHEMBL264 | IC50 | 6.46 | 6.46 | 350.0 | 1 |
| Voltage-gated inwardly rectifying potassium channel KCNH2 CHEMBL240 | IC50 | 6.19 | 5.65 | 640.0 | 3 |
| Butyrylcholinesterase CHEMBL5077 | Ki | 6.19 | 6.19 | 640.0 | 2 |
| NIH3T3 CHEMBL614822 | IC50 | 5.9 | 5.9 | 1260.0 | 1 |
| Butyrylcholinesterase CHEMBL3403 | IC50 | 5.89 | 4.985 | 1280.0 | 22 |
| BV-2 CHEMBL614781 | IC50 | 5.81 | 5.81 | 1540.0 | 1 |
| Cholinesterase CHEMBL2528 | IC50 | 5.7 | 5.425 | 1992.0 | 2 |
| Cholinesterase CHEMBL5763 | Ki | 5.67 | 5.67 | 2140.0 | 1 |
| Butyrylcholinesterase CHEMBL5077 | IC50 | 5.54 | 5.33 | 2900.0 | 5 |
| Unchecked CHEMBL612545 | IC50 | 5.47 | 4.7633 | 3400.0 | 15 |
| MAP/microtubule affinity-regulating kinase 4 CHEMBL5754 | IC50 | 5.28 | 5.28 | 5300.0 | 1 |
| Cholinesterase CHEMBL5763 | Kd | 5.14 | 5.14 | 7200.0 | 1 |
| Cholinesterase CHEMBL1914 | Ki | 4.9 | 4.9 | 12540.0 | 1 |
| Amine oxidase [flavin-containing] B CHEMBL2993 | IC50 | 4.82 | 4.82 | 15000.0 | 3 |
| Amine oxidase [flavin-containing] B CHEMBL2039 | IC50 | 4.82 | 4.76 | 15000.0 | 3 |
| ATP-dependent translocase ABCB1 CHEMBL4302 | IC50 | 4.46 | 4.46 | 34850.0 | 1 |
| Voltage-gated L-type calcium channel CHEMBL2095229 | IC50 | 4.46 | 4.46 | 34300.0 | 1 |
| 3',5'-cyclic-AMP phosphodiesterase 4D CHEMBL288 | IC50 | 4.44 | 4.44 | 36000.0 | 1 |
| U-87 MG CHEMBL614247 | IC50 | 4.33 | 4.33 | 47240.0 | 1 |
| Cytochrome P450 3A4 CHEMBL340 | IC50 | 4.26 | 4.26 | 54680.0 | 1 |
| HT-22 CHEMBL614316 | IC50 | 4.25 | 4.25 | 56420.0 | 1 |
| ATP-binding cassette sub-family C member 4 CHEMBL1743128 | IC50 | 4.14 | 4.14 | 72900.0 | 1 |
| Bile salt export pump CHEMBL6020 | IC50 | 4.11 | 4.11 | 78000.0 | 1 |
| Amyloid-beta precursor protein CHEMBL2487 | IC50 | 4.06 | 4.06 | 87410.0 | 1 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| AUC | 3702.02 | ng.hr.mL-1 | Homo sapiens |
| CL | - | - | Homo sapiens |
| CL | 0.001 | uL/min | Homo sapiens |
| CL | 14.4 | mL.min-1.g-1 | Rattus norvegicus |
| CL | 17.6 | mL.min-1.g-1 | Rattus norvegicus |
| CL | 9.6 | mL.min-1.g-1 | Rattus norvegicus |
| CL | 34.8 | mL.min-1.g-1 | Mus musculus |
| F | 50.0 | % | Canis lupus familiaris |
| F | 92.0 | % | Homo sapiens |
| F | 100.0 | % | Homo sapiens |
| Fu | 0.04 | - | Rattus norvegicus |
| Fu | 0.113 | - | Homo sapiens |
| Fu | 0.134 | - | Macaca fascicularis |
| Fu | 0.134 | - | Canis lupus familiaris |
| Fu | 0.082 | - | Cavia porcellus |
| Fu | 0.1 | - | Mus musculus |
| Fu | 0.07 | - | Rattus norvegicus |
| Fu | 0.111 | - | Rattus norvegicus |
| T1/2 | 1.275 | hr | Rattus norvegicus |
| T1/2 | 1.222 | hr | Rattus norvegicus |
| T1/2 | 70.0 | hr | Homo sapiens |
| T1/2 | 1.298 | hr | Rattus norvegicus |
| T1/2 | 1.21 | hr | Rattus norvegicus |
| T1/2 | 1.6 | hr | Rattus norvegicus |
| T1/2 | 1.317 | hr | Rattus norvegicus |
| T1/2 | 1.26 | hr | Rattus norvegicus |
| T1/2 | 2.417 | hr | Rattus norvegicus |
| T1/2 | 0.7667 | hr | Mus musculus |
| T1/2 | 0.2133 | hr | Homo sapiens |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
Data from ChEMBL 36 via Core Engine